Hodgkin’s lymphoma is a malignant lymphoma, and in advanced stages it usually has a better prognosis if treated. 1. Hodgkin’s lymphoma is mainly a classic Hodgkin’s lymphoma, and in the advanced stage, the 5-year failure-free survival rate is 78.8% and the 5-year survival rate is 86.0%, so the prognosis is better. 2. According to the Chinese Lymphoma Treatment Guidelines, the evaluation of the prognosis of Hodgkin’s lymphoma in the advanced stage needs to be judged according to its manifestations. Generally, for every additional factor, the risk of recurrence increases by about 7% to 8%, so the specific prognosis of an individual varies from person to person. 3. Among the adverse factors are: male; albumin <40 g/L; hemoglobin <105 g/L; age ≥45 years; leukocytes ≥15*10⁹/L; stage IV disease; lymphocytes <8% of leukocytes or count <0.6*10⁹/L. Hodgkin's lymphoma has a high cure rate and it is recommended to detect and treat the disease early to try to avoid delaying the treatment to advanced stages.